Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Stage I or II Micro-invasive Oral Cancer 1Head and Neck Neoplasms 1Dermatitis 1

Interventions

Trastuzumab 351Paclitaxel 334Cyclophosphamide 315Docetaxel 292Capecitabine 181Doxorubicin 180Letrozole 165Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 83Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 68Filgrastim 64Albumin-Bound Paclitaxel 64Magnetic Resonance Spectroscopy 56eribulin 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Reference Standards × Clear all
NCT04603911 2025-01-10

RCT Comparing ESPB Solutions in Breast Surgery

Tufts Medical Center

Phase 2 Completed
75 enrolled
Breast

Breast Neoplasms

NCT01762020 2017-03-08

Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 3 Completed
56 enrolled
Breast

Breast Neoplasms, Dermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡